If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalData Regulatory News (DATA)

Share Price Information for GlobalData (DATA)

Share Price is delayed by 15 minutes
Get Live Data
80.40    -0.60 (-0.74%)
Bid:
80.90
Ask:
81.30
Spread: 0.40 (0.494%)
Market Cap: £558.19m
DATA Live PriceLast checked at - London Stock Exchange

Intraday GlobalData Share Chart

Transaction in Own Shares

23 Aug 2024 07:00

RNS Number : 4977B
GlobalData PLC
23 August 2024
 

23 August 2024

 

 

GlobalData Plc

 

Transaction in Own Shares

 

 

GlobalData Plc ('GlobalData' or the 'Group') announces that, in accordance with the terms of its share buyback programme announced and commenced on 31 July 2024 (the "Share Buyback Programme"), the Company purchased the following number of its ordinary shares of £0.0001 each through Panmure Liberum Limited.

 

 

Date of purchase:

22 August 2024

Aggregate number of ordinary shares of £0.0001 each purchased:

275,000

Lowest price paid per share (GBp):

222.0

Highest price paid per share (GBp):

222.0

Volume weighted average price paid per share (GBp):

222.0

 

The Group will cancel the repurchased shares. Following the purchase of these shares, the remaining number of ordinary shares in issue will be 841,518,898 and the Group holds no ordinary shares in treasury. Therefore, the total voting rights in GlobalData will be 841,518,898. This figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Panmure Liberum Limited as part of the Share Buyback Programme.

 

Aggregate Information:

 

Venue

Volume-weighted average price (pence per share)

Aggregated volume

XLON

222.0

275,000

 

Individual transactions:

 

Number of shares purchased

Transaction price (pence per share)

Time of transaction

Venue

275,000

222.0

10:46:16

AIMX

 

 

ENQUIRIES

 

GlobalData Plc

Mike Danson, Chief Executive Officer

0207 936 6400

Graham Lilley, Chief Financial Officer

J.P. Morgan Cazenove (Nomad, Joint Broker)

0203 493 8000

Bill Hutchings

Mose Adigun

Panmure Liberum (Joint Broker)

0207 886 2500

Rupert Dearden

Dougie McLeod

Investec Bank plc (Joint Broker)

Henry Reast

Virginia Bull 

0207 597 5970

 

FTI Consulting (Financial PR)

0203 727 1000

Edward Bridges

globaldata@fticonsulting.com

Dwight Burden

Emma Hall

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSEAKPAASFLEFA
Date   Source Headline
1st Aug 20227:00 amRNSHalf Year Results
20th Jul 20227:00 amRNSAppointment of Joint Broker
15th Jul 20227:00 amRNSNotice of Interim Results
28th Jun 202212:45 pmRNSAnnual Report FY2021
26th Apr 202212:32 pmRNSResults of AGM
4th Apr 20221:14 pmRNSNotice of AGM
28th Feb 20227:00 amRNSFinal Year Results
24th Feb 20227:00 amRNSHolding(s) in Company
14th Jan 20224:43 pmRNSPDMR Notification
10th Jan 20227:00 amRNSUpdate on FY21 performance and Capital Markets Day
15th Dec 20217:00 amRNSAcquisition of Automotive and Agribusiness Assets
9th Sep 20217:00 amRNSAcquisition of Life Sciences business
28th Jul 20219:09 amRNSPDMR Notification
26th Jul 20217:00 amRNSUnaudited interim report
2nd Jul 202112:27 pmRNSInterim Accounts
24th Jun 202110:37 amRNSBoard Change
1st Jun 20214:26 pmRNSPDMR Dealing
30th Apr 20217:00 amRNSBoard Change
20th Apr 202110:56 amRNSResults of AGM
26th Mar 20217:00 amRNSNotice of AGM and the proposed appointment of NED
26th Mar 20217:00 amRNSInterim Accounts
15th Mar 20217:00 amRNSAnnual Report
1st Mar 20217:01 amRNSBoard Changes
1st Mar 20217:00 amRNSFinal Results For The Year Ended 31 December 2020
12th Feb 20214:12 pmRNSHolding(s) in Company
18th Jan 20219:17 amRNSDirector/PDMR Shareholding
5th Jan 20217:00 amRNSBoard Changes
21st Dec 20209:49 amRNSDirector/PDMR Shareholding
25th Nov 20207:00 amRNSAppointment of Nomad and Broker
25th Nov 20207:00 amRNSTrading Update
9th Oct 20203:47 pmRNSTransfer of Shares out of Treasury
1st Sep 202012:16 pmRNSHolding(s) in Company
21st Aug 20208:55 amRNSAppointment of Joint Corporate Broker
27th Jul 20207:00 amRNSUnaudited Interim Report
21st May 20204:10 pmRNSEmployee Share Options and PDMR Dealing
19th May 20201:06 pmRNSIncreased Banking Facilities
21st Apr 202011:05 amRNSResults of AGM
21st Apr 20207:00 amRNSCOVID-19 Update, Dividend Deferral and AGM
27th Mar 202011:55 amRNSNotice of AGM
3rd Mar 20207:45 amRNSAnnual Report and Accounts
24th Feb 20207:00 amRNSFinal Results For The Year Ended 31 December 2019
16th Jan 20207:00 amRNSUpdate on Directorate Change
30th Oct 201910:59 amRNSHolding(s) in Company
3rd Oct 20197:00 amRNSDirectorate Change
29th Jul 20197:00 amRNSUnaudited Interim Report
19th Jul 20197:00 amRNSNotice of Results
23rd May 20197:00 amRNSNotice of Capital Markets Day
26th Apr 201912:57 pmRNSDirector/PDMR Dealings
23rd Apr 20194:20 pmRNSResults of AGM
28th Mar 20197:00 amRNSAnnual Report and Accounts and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.